grant | 2023 - 2023
Defining the role of NEK1 mutations in ALS
Perron Institute for Neurological and Translational Science
Grant no. 21373.
grant | 2023 - 2023
Modulation of the autophagy pathway to clear TDP-43 aggregation as a therapeutic strategy for ALS and FTLD
Perron Institute for Neurological and Translational Science
Grant no. 21369.
grant | 2023 - 2023
Perron Institute - SPA Sarah Rea (Ext IRMA 19158)
Perron Institute for Neurological and Translational Science (Australia, Nedlands) - WANRI
Grant no. 21371.
grant | 2022 - 2024
Modulation of the Autophagy Pathway to treat Neurogenerative Diseases
General
Grant no. 21102.
grant | 2022 - 2023
WA Near-miss Awards: Ideas Grants 2021
General
Grant no. 20976.
grant | 2021 - 2025
Antisense oligonucleotides targeted to the p62 PB1 domain as a potential therapy in ALS.
General
Grant no. 20203.
grant | 2021 - 2021
Investigation of gene variations associated with Pagets disease of bone within a Western Australian cohort
General
Grant no. 19907.
grant | 2020 - 2021
Antisense oligonucleotide targeting of p62-mediated TDP-43 pathology as a treatment for amyotrophic lateral sclerosis
General
Grant no. 19825.
grant | 2020 - 2020
Defining the interaction between p62 and TDP-43 as a potential therapeutic target for Amyotrophic lateral sclerosis and Frontotemporal Dementia
General
Grant no. 19435.
grant | 2020 - 2020
Enhancing the TBK1-p62 axis as a therapeutic strategy for frontotemporal lobar degeneration.
General
Grant no. 19434.
grant | 2020 - 2022
Modulation of accessory pathways to ameliorate neurodegenerative disease
General
Grant no. 19832.
grant | 2020 - 2021
Risk genes in sporadic Inclusion Body Myositis (IBM)
General
Grant no. 19819.
grant | 2020 - 2021
Validation of motor neuron disease patient olfactory neural stem cells as a drug evaluation platform
General
Grant no. 19968.